Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
24/09/2025 08:13
Sept 24 (Reuters) - Implantica AG 8IM1q.F: FDA PROVIDES FAVORABLE FEEDBACK ON REFLUXSTOP PMA MODULE 3 TO MEET FDA ON OCTOBER 3 TO DISCUSS FEEDBACK Source text: ID:nWkr8cVzxX Further company coverage: [8IM1q.F] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3